Fidelity Advisor Biotechnology Fund APGE Holdings History
Fidelity Advisor Biotechnology Fund's Apogee Therapeutics Inc Holding Summary
As of 2025-04-30, FIDELITY ADVISOR SERIES VII held 30,554.00 shares of Apogee Therapeutics Inc(APGE), totaling $637,360.00. This investment constitutes 0.05% of their stock portfolio, and FIDELITY ADVISOR SERIES VII now holds 0.05% of the outstanding Apogee Therapeutics Inc(APGE) stock.
The initial trade took place in 2023Q3. And since then Fidelity Advisor Biotechnology Fund has made 2 purchases of APGE, at an average price of $34.19, for a total of 1.34 Mil shares. In addition, there have been 2 sales at an average price of $43.09 for 1.30 Mil shares. Based on historical transaction data and APGE's current price of $39.31, Fidelity Advisor Biotechnology Fund's estimated gain on his APGE holdings is $11.76 Mil, reflecting a 25.76% gain to date.
Fidelity Advisor Biotechnology Fund APGE ($39.31) Holding Chart
Fidelity Advisor Biotechnology Fund APGE ($39.31) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
